Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (23) Remove All (23) filter
  • News & Articles (16)
  • Researcher Profiles (3)
  • General (3)
  • Research (1)

Search found 23 items

All
Cancer immunotherapy drugs hold hope for some, but there’s still a way to go
Category: News & Articles
... (Keytruda) and nivolumab (Opdivo) are heralding this new era in cancer treatment. Some people taking these drugs can see their cancer completely disappear;  there’s nothing left to see on their ... of people with melanoma , and will soon be available for people with kidney and lung cancers. Trials continue in most types of cancer . ...
Campaign kick-starts cancer ‘biobank’ conversation
Category: News & Articles
A new website was established by the Hunter Cancer Research Alliance to promote the long-term benefits of storing cancer material for future research use. A new website – ... Mater Newcastle who are studying cancers of the brain, breast, bowel, kidney, lung, pancreas and prostate, among others. But more samples are ...
Unbeaten Support: Vital funds for ovarian cancer
Category: News & Articles
... thanks Cheryl for her efforts to raise vital funds for ovarian cancer research. Cheryl Milburn relished life with a loving husband and ... couldn’t find any. “He sent me on my way saying it was probably kidney issues. He was usually very good at picking things up, but he ... referred to a gynaecologist where a CT scan confirmed she had ovarian cancer. Across the next ten years, Cheryl would undergo a hysterectomy, ...
Repurposing an old discovery: Targeting a molecule in a children’s cancer
Category: News & Articles
... Xu Dong Zhang and his team have discovered a way to combat a form of cancer most common in children under five  – neuroblastoma .   ... Xu Dong Zhang and his team have discovered a way to combat a form of cancer most common in children under five  – neuroblastoma .   ... of the United States of America. Neuroblastoma is a type  of cancer that can be found anywhere in the body   but is most commonly ...
Prostate cancer trial sparks treatment time reduction
Category: News & Articles
... to improve targeting accuracy and reduce treatment time for prostate cancer patients undergoing radiotherapy. Hunter researchers have ... to improve targeting accuracy and reduce treatment time for prostate cancer patients undergoing radiotherapy. The SPARK trial studies an ... to other cancers affected by motion, including lung, liver, kidney and pancreas cancers. This Australian technology could become the ...
Study shows higher cancer risk of pre-transplant therapy
Category: News & Articles
The use of immunosuppression therapy prior to kidney transplantation elevates the risk of all cancers – particularly ... and Paul Trevillian. The use of immunosuppression therapy prior to kidney transplantation elevates the risk of all cancers – particularly ... data from the Australian Institute of Health and Welfare’s National Cancer Registry. “Clinicians have known for some time that the ...
Unlocking immune secrets in cancer cells
Category: News & Articles
... of the tumour microenvironment has been mapped by an international cancer team involving Hunter researcher Dr Craig Gedye , seeking to build a clearer picture of how the immune system is involved with cancer . Using cutting-edge imaging technology called Mass Cytometry, ... the 3.5 million measured cells. The study focused on a common type of kidney cancer called a clear cell carcinoma, however Dr Gedye is ...
Craig Gedye
Category: Researcher Profiles
... patient outcomes? I undertake clinical, translational and basic cancer research in melanoma, brain, prostate, bladder and kidney cancers. Why did you get into research? My research career began ... on several fronts. I am working in the lab to better understand kidney cancer. I’ve found ways to grow kidney cancer in the lab, and ...
ProBBANG: Prospective study of Bevacizumab-induced Blood pressure and ANGiogenic factors as predictive biomarkers in colorectal cancer
Category: General
... patients will benefit from a new chemotherapy drug for colorectal cancer. Standard treatment for patients with advanced (metastatic) colorectal cancer is now with the expensive chemotherapy drug bevacizumab (Bev). ... but also can cause some side-effects such as thrombosis, bleeding, kidney disorders and heart failure. There are currently no markers for ...
HMRI Awards Night 2018 Winners
Category: News & Articles
... current PhD students are researching cannabinoid therapies, targeted cancer therapies, dosing in neonates and therapeutic drug monitoring in ... glove, electrical stimulation and virtual reality. HMRI Paediatric Kidney Disease Project Grant Awarded to Associate Professor Kym Rae | Consequences of the in-utero environment on kidney function for infants in the Gomeroi gaaynggal cohort. HMRI ...
  • 1
  • 2
  • 3
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services